FDA Clearance Tracker · DEN130002
TINA-QUANT HBA1C GEN. 2 TEST SYSTEM
Last checked: Nov 19, 2026Latest source record: May 23, 2013 (this decision)Source: openFDAMethods & limitations
Decided
May 23, 2013
De Novo granted
Time to decision
59 days
Received Mar 25, 2013. Calendar days, including time FDA spent waiting on the applicant.
Pathway
De Novo
Post-NSE
Device class
Class II
The decision
- FDA number
- DEN130002
- Device name
- TINA-QUANT HBA1C GEN. 2 TEST SYSTEM
- Applicant
- Roche Diagnostics
- Applicant location
- Indianapolis, IN
- Received
- Mar 25, 2013
- Decided
- May 23, 2013
- Decision
- De Novo granted
- Submission type
- Post-NSE
Device type
- Device type
- Hemoglobin A1c Test System (PDJ)
- Device class
- Class II
- Regulation
- 21 CFR 862.1373
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- FDA granted this as a De Novo request, which means it created a new device type. There was no existing device to compare it to.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for DEN130002
- Decision summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
Other decisions for Roche Diagnostics
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Elecsys HBsAg II quant II RxDxNew device typeDe Novo
DEN260027 · Decided Oct 20, 2026 · 140 days after receipt
Device type: Quantitative Hepatitis B Surface Antigen (SJM) · Laboratory Medicine & Pathology
- Elecsys EBV EBNA IgG510(k)
K260221 · Decided Oct 2, 2026 · 249 days after receipt
Device type: Epstein-Barr Virus, Other (LSE) · Laboratory Medicine & Pathology
- Elecsys EBV VCA IgG510(k)
K260232 · Decided Oct 2, 2026 · 249 days after receipt
Device type: Epstein-Barr Virus, Other (LSE) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.